Novartis CAR-T Patient Assistance Program Could Set Template For Other One-Time Treatments

HHS gives kickback exemption for program to provide Kymriah for free to certain eligible patients regardless of insurance provider. Treatment’s one-time use as a last resort therapy were key to the US government’s advisory opinion reasoning.

Novartis will be able to provide Kymriah for free to some qualified patients.

More from Cell & Gene Therapies

More from Advanced Technologies